semaglutide cardiovascular outcomes news 2025 Effects of on mortality, cardiovascular, and kidney across the cardio-kidney-metabolic continuum: a systematic review and meta-analysis | Diabetology Evaluating the Cardiovascular Benefits of

For my medullary patients the ones with the FDA warning I'm still saying, until we have better data, I can't recommend it

NAFLD is a common metabolic disorder associated with obesity and has a wide range of pathological alterations, such as fatty liver and nonalcoholic steatohepatitis (NASH), which contribute to hepatocellular carcinomas (HCCs)

I feel like nobody is really reading what you are writing, that they blame the weight loss while you measured the first time when you were actually lighter, they explained

Due to limited availability of funding for the GLP-1 survey items, we were unable to collect more detailed information about how and why people were accessing these medications

Hydroxocobalamin B12 injections give you a boost in energy, while also stimulating your metabolism to encourage weight management

For a broader look at common missteps people make on these medications, the post on 5 common mistakes when using GLP-1 for weight loss is a helpful companion read